Demonstrates that apelin analogues confer cardioprotection and reduce blood pressure, highlighting their therapeutic potential against ischemic reperfusion injury.
-NMeLeu17A2 not only provided cardioprotective effects but also significantly lowered blood pressure. These findings highlight the potential of NMeLeu13A2 for targeted therapeutics and underscore the promise of apelin-based analogues in addressing ischemic reperfusion injury.
No takes yet. Share an insight, caveat, or question.
Wijewardane et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: